Last reviewed · How we verify
hUC-MSCs treatment （Double dose）
At a glance
| Generic name | hUC-MSCs treatment （Double dose） |
|---|---|
| Sponsor | Shenzhen Beike Bio-Technology Co., Ltd. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Treatment of Systemic Lupus Erythematosus With Human Umbilical Cord Mesenchymal Stem Cells (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: